BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 19650755)

  • 21. Evaluating the claim of enhanced persistence: the case of osteoporosis and implications for payers.
    Kelton CM; Pasquale MK
    Med Decis Making; 2009; 29(6):690-706. PubMed ID: 19542361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.
    Cramer JA; Silverman S
    Am J Med; 2006 Apr; 119(4 Suppl 1):S12-7. PubMed ID: 16563936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis.
    Woo T; Adachi JD
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):469-81. PubMed ID: 11485341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
    Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I.
    Boonen S; Singer AJ
    Curr Med Res Opin; 2008 Jun; 24(6):1781-8. PubMed ID: 18489813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS; Thiebaud P; McLaughlin-Miley C; Shi J
    Maturitas; 2004 Jul; 48(3):271-87. PubMed ID: 15207894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of osteoporosis in octogenarians].
    Pepersack T
    Rev Med Brux; 2008 Sep; 29(4):311-6. PubMed ID: 18949982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compliance with treatment in osteoporosis patients--an ongoing problem.
    Sambrook P
    Aust Fam Physician; 2006 Mar; 35(3):135-7. PubMed ID: 16525527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence.
    Rabenda V; Hiligsmann M; Reginster JY
    Expert Opin Pharmacother; 2009 Oct; 10(14):2303-15. PubMed ID: 19640210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the prevalence and costs of osteoporosis treatment options in a real-world setting.
    Brixner D
    Am J Manag Care; 2006 May; 12(7 Suppl):S191-8. PubMed ID: 16686588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and treatment of senile osteoporosis and hip fractures.
    Duque G; Demontiero O; Troen BR
    Minerva Med; 2009 Feb; 100(1):79-94. PubMed ID: 19277006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture.
    Talbot JC; Elener C; Praveen P; Shaw DL
    Injury; 2007 Nov; 38(11):1236-40. PubMed ID: 17572417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of osteoporotic fracture by pharmaceutical interventions].
    Nakamura T
    Clin Calcium; 2006 Dec; 16(12):1961-67. PubMed ID: 17142925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug insight: Existing and emerging therapies for osteoporosis.
    Mulder JE; Kolatkar NS; LeBoff MS
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Goals of treatment for osteoporosis].
    Nakamura T
    Clin Calcium; 2008 Oct; 18(10):1389-95. PubMed ID: 18830034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to prevent fractures in the individual with osteoporosis.
    Javaid MK; Cooper C
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):497-515. PubMed ID: 11485343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in bisphosphonate therapy.
    Silverman SL; Maricic M
    Semin Arthritis Rheum; 2007 Aug; 37(1):1-12. PubMed ID: 17303219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.